Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 16729-550

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 16729-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructurebupren (Chemicalstructure1)

Chemical structure of Buprenorphine Hydrochloride, depicting the molecular arrangement of atoms including hydroxyl, methoxy, and cyclopropyl groups, along with the hydrochloride component.*

FDA Label Image

Chemicalstructurenal (Chemicalstructure2)

Chemical structure of BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE, showing the molecular diagram with bonds, rings, and functional groups, including the HCl and 2H2O hydration notation.*

FDA Label Image

Containerlabel2mgpoint5mg (Containerlabel2mgpoint5mg)

Label for Buprenorphine and Naloxone Sublingual Tablets 2 mg/0.5 mg by Accord Healthcare, Inc. The label shows a 30-tablet package for sublingual use. It includes storage instructions, distributor and manufacturer details, and a barcode. The label emphasizes dispensing with accompanying medication guide and child-resistant packaging requirements.*

FDA Label Image

Containerlabel8mg2mg (Containerlabel8mg2mg)

Label for Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, distributed by Accord Healthcare, Inc. It is indicated as a prescription drug with a package size of 30 tablets. The label includes storage instructions (20° to 25°C), manufacturer details (WES Pharma Inc, Westminster, MD), a barcode, and directions for pharmacists to dispense the medication guide with each prescription.*

FDA Label Image

Fig1

An illustration showing a person placing a sublingual tablet under their tongue. The image demonstrates the administration route for sublingual tablets, such as buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.